Effects of HIV on Respiratory Tract Defenses

Key points
- The hallmark of the effect of HIV infection on host immune response is a progressive reduction in the number of circulating CD4+ lymphocytes or "T-helper" cells.
- Alveolar macrophages from persons with HIV infection have reduced chemotactic ability, but the ability to phagocytose and kill ingested organisms is thought to be normal.
- The CD4+ lymphocyte plays a central role in orchestrating both cellular and humoral immune responses.
- Consequently, as HIV disease becomes progressively more severe, the ability of the host to ward off or contain infecting organisms becomes more and more limited.
The hallmark of the effect of HIV infection on host immune response is a progressive reduction in the number of circulating CD4+ lymphocytes or "T-helper" cells. The CD4+ lymphocyte plays a central role in orchestrating both cellular and humoral immune responses. Consequently, as HIV disease becomes progressively more severe, the ability of the host to ward off or contain infecting organisms becomes more and more limited. Many of the immune defects that have been described in HIV-infected persons can be attributed simply to a reduction in numbers of CD4+ lymphocytes. However, HIV infection also induces functional defects in these cells: Circulating CD4+ lymphocytes fail to proliferate in response to antigens that have been encountered previously. This loss of memory may account for failure to continue to contain infections, such as with Mycobacterium tuberculosis or P. carinii, and for the inability to prevent reinfection, as may occur with M. tuberculosis. Reductions in production of interleukin-2 (IL-2) and interferon-gamma by CD4+ lymphocytes from HIV-infected persons have also been demonstrated. These cytokines are responsible for stimulating clonal proliferation of specifically activated alveolar macrophages and lymphocytes. Defects in production of IL-2 and interferon-gamma are detectable early in the course of HIV infection and account for a functional decrease in immune response out of proportion to reduced numbers of circulating CD4+ lymphocytes.
Alveolar macrophages from persons with HIV infection have reduced chemotactic ability, but the ability to phagocytose and kill ingested organisms is thought to be normal. Alveolar macrophages express CD4 surface antigens and thus can be infected with HIV, yet they remain viable. It has been postulated that these cells can serve as reservoirs in which HIV may be sequestered. The protected virions may then infect other cells. It has also been demonstrated that cytokines, especially tumor necrosis factor-alpha and IL-3, stimulated by opportunistic infections such as tuberculosis, result in upregulation of HIV production within macrophages. Given these findings, the alveolar macrophage may play roles in protecting both the host and the virus and may contribute to accelerated HIV disease in the presence of opportunistic infections.
Written and revised by
David Cohen, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Infections, HIV & STIs →
NewsLong-term health effects from West Nile illnesses
More than a year after being diagnosed with a West Nile virus infection, half of the patients have ongoing health complaints including fatigue, memory problems, headaches, depression, and tremors, according to an…
18 August 2006
NewsResearch Suggests Therapy Against Side Effects of Smallpox Vaccine
Smallpox is considered a potential terrorist weapon, but millions of people in the United States are currently advised not to get a vaccine to the disease because they are susceptible to developing a severe adverse…
22 March 2006
NewsClimate change may affect length of respiratory infection season
Rising global temperatures over the past two decades may be responsible for a shortened season of a serious respiratory illness in the United Kingdom, according to an article in the March 1 issue of Clinical Infectious…

